Home/Filings/4/0001294002-05-000004
4//SEC Filing

THEOFAN GEORGIA 4

Accession 0001294002-05-000004

CIK 0000817785other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 6:18 PM ET

Size

4.8 KB

Accession

0001294002-05-000004

Insider Transaction Report

Form 4
Period: 2005-01-19
THEOFAN GEORGIA
VP, Clinical Development
Transactions
  • Award

    Common Stock

    2004-12-31$1.61/sh+1,902$3,06214,929 total
Footnotes (1)
  • [F1]Matching company contribution to 401K account.

Issuer

IMMUNE RESPONSE CORP

CIK 0000817785

Entity typeother

Related Parties

1
  • filerCIK 0001280158

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 6:18 PM ET
Size
4.8 KB